Published in Neoplasia on January 12, 2001
Multiple independent variants at the TERT locus are associated with telomere length and risks of breast and ovarian cancer. Nat Genet (2013) 4.35
Human telomerase and its regulation. Microbiol Mol Biol Rev (2002) 3.11
Coexistence of alternative lengthening of telomeres and telomerase in hTERT-transfected GM847 cells. Mol Cell Biol (2001) 1.99
Natural and pharmacological regulation of telomerase. Nucleic Acids Res (2002) 1.92
Quantitation of telomerase components and hTERT mRNA splicing patterns in immortal human cells. Nucleic Acids Res (2001) 1.73
Human Pot1 (protection of telomeres) protein: cytolocalization, gene structure, and alternative splicing. Mol Cell Biol (2002) 1.69
NOTCH2 and FLT3 gene mis-splicings are common events in patients with acute myeloid leukemia (AML): new potential targets in AML. Blood (2014) 1.44
Telomeres, stem cells, and hematology. Blood (2008) 1.34
Vertebrate POT1 restricts G-overhang length and prevents activation of a telomeric DNA damage checkpoint but is dispensable for overhang protection. Mol Cell Biol (2006) 1.23
Quantification of hTERT splice variants in melanoma by SYBR green real-time polymerase chain reaction indicates a negative regulatory role for the beta deletion variant. Neoplasia (2008) 1.07
Characterization of novel alternative splicing sites in human telomerase reverse transcriptase (hTERT): analysis of expression and mutual correlation in mRNA isoforms from normal and tumour tissues. BMC Mol Biol (2006) 1.07
Recombination-based telomere maintenance is dependent on Tel1-MRN and Rap1 and inhibited by telomerase, Taz1, and Ku in fission yeast. Mol Cell Biol (2007) 1.04
The major reverse transcriptase-incompetent splice variant of the human telomerase protein inhibits telomerase activity but protects from apoptosis. Cancer Res (2013) 1.04
Expression profile of a gamma-deletion variant of the human telomerase reverse transcriptase gene. Neoplasia (2003) 1.01
Direct involvement of the TEN domain at the active site of human telomerase. Nucleic Acids Res (2010) 0.98
Telomerase regulation. Mutat Res (2011) 0.98
Imatinib mesylate (Gleevec) downregulates telomerase activity and inhibits proliferation in telomerase-expressing cell lines. Br J Cancer (2005) 0.97
Alternatively spliced telomerase reverse transcriptase variants lacking telomerase activity stimulate cell proliferation. Mol Cell Biol (2012) 0.97
Alternative RNA splicing and cancer. Wiley Interdiscip Rev RNA (2013) 0.96
Human telomerase activity regulation. Mol Biol Rep (2010) 0.94
Telomere lengthening and other functions of telomerase. Acta Naturae (2012) 0.92
Differentiating alternative splice variant patterns of human telomerase reverse transcriptase in thyroid neoplasms. Thyroid (2008) 0.92
Alternative splicing regulation of telomerase: a new paradigm? Trends Genet (2014) 0.90
Molecular regulation of telomerase activity in aging. Protein Cell (2011) 0.90
Quantitative relationship between functionally active telomerase and major telomerase components (hTERT and hTR) in acute leukaemia cells. Br J Cancer (2005) 0.89
Telomeric G-quadruplexes are a substrate and site of localization for human telomerase. Nat Commun (2015) 0.88
Reactivation of telomerase in cancer. Cell Mol Life Sci (2016) 0.87
Quantification of alternative splicing variants of human telomerase reverse transcriptase and correlations with telomerase activity in lung cancer. PLoS One (2012) 0.86
Telomerase-dependent and independent telomere maintenance and its clinical implications in medullary thyroid carcinoma. J Clin Endocrinol Metab (2014) 0.86
Human telomerase activity, telomerase and telomeric template expression in hepatic stem cells and in livers from fetal and postnatal donors. Eur J Gastroenterol Hepatol (2009) 0.85
Microenvironmental regulation of telomerase isoforms in human embryonic stem cells. Stem Cells Dev (2014) 0.84
Mechanism of telomerase activation by v-Rel and its contribution to transformation. J Virol (2006) 0.84
Function, replication and structure of the mammalian telomere. Cytotechnology (2004) 0.84
The role of telomeres and telomerase reverse transcriptase isoforms in pluripotency induction and maintenance. RNA Biol (2016) 0.84
Plasma Leptin, hTERT Gene Expression, and Anthropometric Measures in Obese and Non-Obese Women with Breast Cancer. Breast Cancer (Auckl) (2011) 0.83
Prognostic relevance of hTERT mRNA expression in ductal adenocarcinoma of the pancreas. Neoplasia (2008) 0.83
Colony forming unit endothelial cells do not exhibit telomerase alternative splicing variants and activity. Iran Biomed J (2013) 0.82
Telomere length is related to alternative splice patterns of telomerase in thyroid tumors. Am J Pathol (2011) 0.82
The regulation of telomerase in oncogenesis. Acta Naturae (2009) 0.81
Alternative splicing and nonsense-mediated decay regulate telomerase reverse transcriptase (TERT) expression during virus-induced lymphomagenesis in vivo. BMC Cancer (2010) 0.81
HTERT mRNA partially regulates telomerase activity in gastric adenocarcinoma and adjacent normal gastric mucosa. Dig Dis Sci (2005) 0.81
Molecular analysis of T-DNA insertion mutants identified putative regulatory elements in the AtTERT gene. J Exp Bot (2011) 0.81
Telomerase gene expression in the chicken: Telomerase RNA (TR) and reverse transcriptase (TERT) transcript profiles are tissue-specific and correlate with telomerase activity. Age (Dordr) (2006) 0.79
Telomerase Activity is Downregulated Early During Human Brain Development. Genes (Basel) (2016) 0.79
Insights into the evolution of mammalian telomerase: platypus TERT shares similarities with genes of birds and other reptiles and localizes on sex chromosomes. BMC Genomics (2012) 0.78
Tiptoeing to chromosome tips: facts, promises and perils of today's human telomere biology. Philos Trans R Soc Lond B Biol Sci (2002) 0.77
A Common Cancer Risk-Associated Allele in the hTERT Locus Encodes a Dominant Negative Inhibitor of Telomerase. PLoS Genet (2015) 0.77
Analytical validation of telomerase activity for cancer early detection: TRAP/PCR-CE and hTERT mRNA quantification assay for high-throughput screening of tumor cells. J Mol Diagn (2004) 0.77
Canis familiaris telomerase reverse transcriptase undergoes alternative splicing. Mamm Genome (2008) 0.77
The role of the JAK-STAT pathway and related signal cascades in telomerase activation during the development of hematologic malignancies. JAKSTAT (2013) 0.77
Dual regulation of TERT activity through transcription and splicing by DeltaNP63alpha. Aging (Albany NY) (2008) 0.76
MDS shows a higher expression of hTERT and alternative splice variants in unactivated T-cells. Oncotarget (2016) 0.76
Alternative Splicing of hTERT Pre-mRNA: A Potential Strategy for the Regulation of Telomerase Activity. Int J Mol Sci (2017) 0.75
Single cell measurement of telomerase expression and splicing using microfluidic emulsion cultures. Nucleic Acids Res (2015) 0.75
Current Insights to Regulation and Role of Telomerase in Human Diseases. Antioxidants (Basel) (2017) 0.75
Changes in telomerase activity due to alternative splicing of human telomerase reverse transcriptase in colorectal cancer. Oncol Lett (2017) 0.75
A biomarker that identifies senescent human cells in culture and in aging skin in vivo. Proc Natl Acad Sci U S A (1995) 32.89
Specific association of human telomerase activity with immortal cells and cancer. Science (1994) 28.20
Telomere shortening associated with chromosome instability is arrested in immortal cells which express telomerase activity. EMBO J (1992) 10.97
TRF2 protects human telomeres from end-to-end fusions. Cell (1998) 10.13
hEST2, the putative human telomerase catalytic subunit gene, is up-regulated in tumor cells and during immortalization. Cell (1997) 8.74
Heterogeneity in telomere length of human chromosomes. Hum Mol Genet (1996) 6.55
Telomere loss: mitotic clock or genetic time bomb? Mutat Res (1992) 6.50
Telomere elongation in immortal human cells without detectable telomerase activity. EMBO J (1995) 6.03
Inhibition of telomerase limits the growth of human cancer cells. Nat Med (1999) 4.96
A mammalian telomerase-associated protein. Science (1997) 4.37
Isolation of a candidate human telomerase catalytic subunit gene, which reveals complex splicing patterns in different cell types. Hum Mol Genet (1997) 3.56
Human telomerase contains evolutionarily conserved catalytic and structural subunits. Genes Dev (1997) 3.47
TLP1: a gene encoding a protein component of mammalian telomerase is a novel member of WD repeats family. Cell (1997) 3.30
Modifications of a telomeric repeat amplification protocol (TRAP) result in increased reliability, linearity and sensitivity. Nucleic Acids Res (1995) 3.16
Telomere shortening and apoptosis in telomerase-inhibited human tumor cells. Genes Dev (1999) 3.04
Expression of TERT in early premalignant lesions and a subset of cells in normal tissues. Nat Genet (1998) 2.56
Telomerase activity in human development is regulated by human telomerase reverse transcriptase (hTERT) transcription and by alternate splicing of hTERT transcripts. Cancer Res (1998) 2.54
The human telomerase catalytic subunit hTERT: organization of the gene and characterization of the promoter. Hum Mol Genet (1999) 2.52
Lethality induced by a single site-specific double-strand break in a dispensable yeast plasmid. Proc Natl Acad Sci U S A (1993) 2.44
Inhibition of human telomerase in immortal human cells leads to progressive telomere shortening and cell death. Proc Natl Acad Sci U S A (1999) 2.36
[Principle of marginotomy in template synthesis of polynucleotides]. Dokl Akad Nauk SSSR (1971) 2.26
Genomic organization and promoter characterization of the gene encoding the human telomerase reverse transcriptase (hTERT). Gene (1999) 2.22
The telomere lengthening mechanism in telomerase-negative immortal human cells does not involve the telomerase RNA subunit. Hum Mol Genet (1997) 1.97
Human telomerase RNA and telomerase activity in immortal cell lines and tumor tissues. Cancer Res (1996) 1.87
Expression profile of the putative catalytic subunit of the telomerase gene. Cancer Res (1998) 1.57
Telomere maintenance mechanisms and cellular immortalization. Curr Opin Genet Dev (1999) 1.43
Regulation of telomerase by alternate splicing of human telomerase reverse transcriptase (hTERT) in normal and neoplastic ovary, endometrium and myometrium. Int J Cancer (2000) 1.24
SV40-transformed human cells in crisis exhibit changes that occur in normal cellular senescence. Exp Cell Res (1994) 0.91
Up-regulation of telomerase in human B lymphocytes occurs independently of cellular proliferation and with expression of the telomerase catalytic subunit. Eur J Immunol (1999) 0.87
Mammalian DNA repair responses and genomic instability. EXS (1996) 0.80
Evidence for an alternative mechanism for maintaining telomere length in human tumors and tumor-derived cell lines. Nat Med (1997) 6.55
Telomere elongation in immortal human cells without detectable telomerase activity. EMBO J (1995) 6.03
Telomere maintenance by recombination in human cells. Nat Genet (2000) 5.14
A mammalian telomerase-associated protein. Science (1997) 4.37
Topographical control of cells. Biomaterials (1997) 4.31
Telomerase-negative immortalized human cells contain a novel type of promyelocytic leukemia (PML) body. Cancer Res (1999) 4.24
Is the potential of teenage consultations being missed?: a study of consultation times in primary care. Fam Pract (1994) 4.15
Diversity arrays: a solid state technology for sequence information independent genotyping. Nucleic Acids Res (2001) 4.13
Isolation of a candidate human telomerase catalytic subunit gene, which reveals complex splicing patterns in different cell types. Hum Mol Genet (1997) 3.56
Reconstitution of human telomerase activity in vitro. Curr Biol (1998) 3.51
Human telomerase contains evolutionarily conserved catalytic and structural subunits. Genes Dev (1997) 3.47
The association football medical research programme: an audit of injuries in professional football. Br J Sports Med (2001) 3.34
Telomere shortening and apoptosis in telomerase-inhibited human tumor cells. Genes Dev (1999) 3.04
Depressive disorders in Europe: prevalence figures from the ODIN study. Br J Psychiatry (2001) 2.94
The effectiveness of one-to-one risk communication interventions in health care: a systematic review. Med Decis Making (2000) 2.68
A molecular, isozyme and morphological map of the barley (Hordeum vulgare) genome. Theor Appl Genet (1993) 2.66
Genetic map of diploid wheat, Triticum monococcum L., and its comparison with maps of Hordeum vulgare L. Genetics (1996) 2.59
Measuring the involvement of patients in shared decision-making: a systematic review of instruments. Patient Educ Couns (2001) 2.33
Women's role and satisfaction in the decision to have a caesarean section. Med J Aust (1999) 2.27
Alternative lengthening of telomeres and survival in patients with glioblastoma multiforme. Lancet (2003) 2.26
Recombinant human interleukin 10 in the treatment of patients with mild to moderately active Crohn's disease. The Interleukin 10 Inflammatory Bowel Disease Cooperative Study Group. Gastroenterology (2000) 2.23
Estimating psychological treatment effects from a randomised controlled trial with both non-compliance and loss to follow-up. Br J Psychiatry (2003) 2.19
Impact of cleaning and other interventions on the reduction of hospital-acquired Clostridium difficile infections in two hospitals in England assessed using a breakpoint model. J Hosp Infect (2013) 2.11
Coexistence of alternative lengthening of telomeres and telomerase in hTERT-transfected GM847 cells. Mol Cell Biol (2001) 1.99
The telomerase reverse transcriptase is limiting and necessary for telomerase function in vivo. Curr Biol (2000) 1.97
The telomere lengthening mechanism in telomerase-negative immortal human cells does not involve the telomerase RNA subunit. Hum Mol Genet (1997) 1.97
The barley stem rust-resistance gene Rpg1 is a novel disease-resistance gene with homology to receptor kinases. Proc Natl Acad Sci U S A (2002) 1.93
Functional multimerization of the human telomerase reverse transcriptase. Mol Cell Biol (2001) 1.90
Establishment and characterization of SV40 T-antigen immortalized human esophageal epithelial cells. Cancer Res (1991) 1.88
Telomere dynamics and telomerase activity in in vitro immortalised human cells. Eur J Cancer (1997) 1.87
Measurement by quantitative PCR of changes in HPRT, PGK-1, PGK-2, APRT, MTase, and Zfy gene transcripts during mouse spermatogenesis. Nucleic Acids Res (1990) 1.86
Alterations in p53 and p16INK4 expression and telomere length during spontaneous immortalization of Li-Fraumeni syndrome fibroblasts. Mol Cell Biol (1995) 1.85
The impact of a brief motivational intervention with opiate users attending a methadone programme. Addiction (1995) 1.80
Teenage pregnancy in the United Kingdom in the 1990s: the implications for primary care. Fam Pract (1995) 1.76
Selective toxicity of MKT-077 to cancer cells is mediated by its binding to the hsp70 family protein mot-2 and reactivation of p53 function. Cancer Res (2000) 1.70
Human bronchial epithelial cells with integrated SV40 virus T antigen genes retain the ability to undergo squamous differentiation. Differentiation (1988) 1.64
Genetic diversity of Plasmodium falciparum and its relationship to parasite density in an area with different malaria endemicities in West Uganda. Trop Med Int Health (2001) 1.61
Polymerization defects within human telomerase are distinct from telomerase RNA and TEP1 binding. Mol Biol Cell (2000) 1.60
Guidance and activation of murine macrophages by nanometric scale topography. Exp Cell Res (1996) 1.56
Cyclin E2, a novel G1 cyclin that binds Cdk2 and is aberrantly expressed in human cancers. Mol Cell Biol (1999) 1.53
SV40-induced immortalization of human cells. Crit Rev Oncog (1994) 1.51
Establishment of a human in vitro mesothelial cell model system for investigating mechanisms of asbestos-induced mesothelioma. Am J Pathol (1989) 1.51
Vaults and telomerase share a common subunit, TEP1. J Biol Chem (1999) 1.50
Nantotechniques and approaches in biotechnology. Trends Biotechnol (2001) 1.50
Tamoxifen induces accumulation of MCF 7 human mammary carcinoma cells in the G0/G1 phase of the cell cycle. Eur J Cancer Clin Oncol (1983) 1.49
Mildly dyskaryotic smear results: does it matter what women know? Fam Pract (1998) 1.47
The genetic diversity of UK, US and Australian cultivars of Triticum aestivum measured by DArT markers and considered by genome. Theor Appl Genet (2007) 1.47
Telomere length dynamics in telomerase-positive immortal human cell populations. Exp Cell Res (1998) 1.47
A cancer risk assessment of di(2-ethylhexyl)phthalate: application of the new U.S. EPA Risk Assessment Guidelines. Regul Toxicol Pharmacol (1999) 1.47
Pigeonpea genomics initiative (PGI): an international effort to improve crop productivity of pigeonpea (Cajanus cajan L.). Mol Breed (2009) 1.46
Loss of p16INK4 expression by methylation is associated with lifespan extension of human mammary epithelial cells. Cancer Res (1998) 1.45
Telomere maintenance mechanisms and cellular immortalization. Curr Opin Genet Dev (1999) 1.43
Inactivation of tumor suppressor p53 by mot-2, a hsp70 family member. J Biol Chem (1998) 1.43
An upper limit on the stochastic gravitational-wave background of cosmological origin. Nature (2009) 1.42
Identification of candidate alternative lengthening of telomeres genes by methionine restriction and RNA interference. Oncogene (2007) 1.42
Strontium phosphate transfection of human cells in primary culture: stable expression of the simian virus 40 large-T-antigen gene in primary human bronchial epithelial cells. Mol Cell Biol (1987) 1.39
Differential sensitivity of human breast cancer cell lines to the growth-inhibitory effects of tamoxifen. Cancer Res (1985) 1.37
Ototoxicity in patients receiving cisplatin: importance of dose and method of drug administration. Cancer Treat Rep (1982) 1.37
Mental health and nutritional status among the adult Serbian minority in Kosovo. JAMA (2000) 1.37
Quasi-Laue neutron-diffraction study of the water arrangement in crystals of triclinic hen egg-white lysozyme. Acta Crystallogr D Biol Crystallogr (1999) 1.35
Mammalian stanniocalcins and cancer. Endocr Relat Cancer (2003) 1.35
Repression of an alternative mechanism for lengthening of telomeres in somatic cell hybrids. Oncogene (1999) 1.34
Efficient literature searching in diffuse topics: lessons from a systematic review of research on communicating risk to patients in primary care. Health Libr Rev (1999) 1.32
Methylation of the human telomerase gene CpG island. Cancer Res (2000) 1.31
Comparison of production of transforming growth factor-beta and platelet-derived growth factor by normal human mesothelial cells and mesothelioma cell lines. Cancer Res (1987) 1.30
A novel human cDNA highly homologous to the fish hormone stanniocalcin. Mol Cell Endocrinol (1995) 1.30
New depths in cell behaviour: reactions of cells to nanotopography. Biochem Soc Symp (1999) 1.29
The MetaFam Server: a comprehensive protein family resource. Nucleic Acids Res (2001) 1.29
It doesn't cost anything just to ask, does it? The ethics of questionnaire-based research. J Med Ethics (2002) 1.27
Characteristics of tumor cell bioactivity in oncogenic osteomalacia. Mol Cell Endocrinol (1996) 1.25
Neutron Laue diffractometry with an imaging plate provides an effective data collection regime for neutron protein crystallography. Nat Struct Biol (1997) 1.24
Direct determination of the positions of the deuterium atoms of the bound water in -concanavalin A by neutron Laue crystallography. Acta Crystallogr D Biol Crystallogr (2000) 1.23
Synergistic and hierarchical adhesive and topographic guidance of BHK cells. Exp Cell Res (1996) 1.20
Low temperature sensing in tulip (Tulipa gesneriana L.) is mediated through an increased response to auxin. J Exp Bot (2000) 1.19
Activation of macrophage-like cells by multiple grooved substrata. Topographical control of cell behaviour. Cell Biol Int (1995) 1.18
Mapping of β-glucan content and β-glucanase activity loci in barley grain and malt. Theor Appl Genet (1995) 1.18
Do the homeless get a fair deal from general practitioners? J R Soc Health (1997) 1.14
High voltage electric injury. Am J Surg (1978) 1.14
Anxiety among women with mild dyskaryosis: a randomized trial of an educational intervention. Br J Gen Pract (1999) 1.13
Upper limits on a stochastic background of gravitational waves. Phys Rev Lett (2005) 1.11
The Pad1+ gene encodes a subunit of the 26 S proteasome in fission yeast. J Biol Chem (1998) 1.11
Stanniocalcin 1 and 2 are secreted as phosphoproteins from human fibrosarcoma cells. Biochem J (2000) 1.10
Correction of the copper transport defect of Menkes patient fibroblasts by expression of the Menkes and Wilson ATPases. J Biol Chem (1998) 1.10
Assignment of SV40-immortalized cells to more than one complementation group for immortalization. Exp Cell Res (1993) 1.10
The stem rust resistance gene Rpg5 encodes a protein with nucleotide-binding-site, leucine-rich, and protein kinase domains. Proc Natl Acad Sci U S A (2008) 1.09
E2F-1 blocks terminal differentiation and causes proliferation in transgenic megakaryocytes. Mol Cell Biol (1996) 1.09
Comparative mapping of the barley genome with male and female recombination-derived, doubled haploid populations. Mol Gen Genet (1995) 1.08
p16(INK4a) and the control of cellular proliferative life span. Carcinogenesis (1999) 1.08
The clinical effectiveness and cost-effectiveness of management strategies for sciatica: systematic review and economic model. Health Technol Assess (2011) 1.07
Development and assessment of DArT markers in triticale. Theor Appl Genet (2011) 1.05
Homocysteine and cognitive decline in healthy elderly. Dement Geriatr Cogn Disord (2001) 1.03
High-throughput genotyping of hop (Humulus lupulus L.) utilising diversity arrays technology (DArT). Theor Appl Genet (2011) 1.03